Iron administration and clinical outcomes in hemodialysis patients

Journal of the American Society of Nephrology

Volumn 13, Issue 3, 2002, Pages 734-744

  Feldman, Harold I ^a   Santanna, Jill ^a   Wensheng, G U O ^a   Furst, Howard ^a   Franklin, Eunice ^a   Joffe, Marshall ^a   Marcus, Sue ^a   Faich, Gerald ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON DEXTRAN;

ADULT; AGED; ANEMIA; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DEMOGRAPHY; DOSE RESPONSE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURVIVAL; UNITED STATES;

EID: 0036191165     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
2. Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously
3. The use of iron in patients on chronic dialysis: Mistake and misconceptions
4. Importance of iron supply for erythropoietin therapy
5. A randomised controlled study of iron supplementation in patients treated with erythropoietin
6. Reduction of recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation
7. Hematologic and erythropoietin responses to iron dextran in the hemodialysis environment
8. Regular low dose intravenous iron therapy improves response to erythropoietin in hemodialysis patients
9. Economic appraisal of maintenance parenteral iron administration in treatment of the anemia in chronic haemodialysis patients
10. Bacterial transferrin receptors - Structure, function and contribution to virulence
11. Iron and virulence in the family Enterobacteriaceae
12. Impaired phagocytic activity of neutrophils in patients receiving haemodialysis: The critical role of iron overload
13. Impairment of phagocyte oxidative metabolism in hemodialyzed patients with iron overload
14. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis
15. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients
16. Correction of deficient phagocytosis during erythropoietin treatment in maintenance hemodialysis patients
17. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency
18. Listeriosis in patients with long-term hemodialysis and transfusional iron overload
19. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis
20. Bacteraemia by Yersinia and other microorganisms in haemodialysis patients: A role for the iron-overload
21. Iron overload in haemodialysis patients increases the risk of bacteraemia: A prospective study
22. Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infections: Beneficial effects of desferrioxamine
23. Risk factors for bacterial infections in chronic haemodialysis adult patients: A multicentre prospective survey
24. Frequent iron dosing is associated with higher infectious deaths
25. Intravenous iron dosing patterns and hospitalization
26. Intravenous iron dosing patterns and mortality
27. Infectious hospitalization risk in IV iron-treated patients
28. Parenteral iron and infection mortality risk in hemodialysis patients
29. Nonparametric estimation from incomplete observations
30. Regression models and life tables
31. The behavior of maximum likelihood estimates under non-standard conditions
32. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
33. Longitudinal data analysis for discrete and continuous outcomes
34. Yersinia infections in patients with homozygous beta-thalassemia associated with iron overload and its treatment
35. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy
36. Is iron sufficiency a risk factor in ischemic heart disease?
37. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians
38. Dietary iron intake and risk of coronary heart disease among men
39. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients
40. Hematocrit level and associated mortality in hemodialysis patients